Table 4.
Estimations of maximum human infectious units per vaccine dose for a range of potential adventitious agents
| Virus/agent | Human infectious dose per vaccine dose (log10) |
|---|---|
| Influenza virus | −15.9 |
| Adenovirus | −9.9 |
| Herpes simplex virus | −9.9 |
| Other herpes virus (human herpesviruses 2–8) | −10.0 |
| Parainfluenza | −13.9 |
| Respiratory syncytial virus | −14.8 |
| Mumps/measles virus | −9.8 |
| Coronavirus | −14.0 |
| Rhinovirus | −12.4 |
| Enterovirus | −11.7 |
| SV40, JC/BK polyomavirus | −9.5 |
| Hepatitis B, C, G | −10.9 |
| Human retrovirus | −13.4 |
| Mammalian reovirus | −6.1 |
| Avian retrovirus | −13.6 |
| Avian polyomavirus | −8.9 |
| Avian reovirus | −9.7 |
| Avian birnavirus | −12.1 |
| Avian circovirus | −9.7 |
| Porcine circovirus | −11.7 |
| Minute virus of mice parvovirus | −13.9 |
| Mycoplasma | −13.0 |
| Chlamydia | −13.3 |